Company profile

Deinove is a biotechnology company specializing in the development of production processes of specialty ingredients for the health, nutrition and cosmetics industries. These production methods are sustainable and competitive production alternative and embody a new source of innovative natural ingredients. For this, Deinove relies on its bank of 6,000 rare bacterial strains, principally with the genus Deinococcus, and its dedicated genetic, fermentation and metabolic engineering platform. Based in Montpellier, Deinove employs about 62 people and has registered more than 300 patents internationally.

Source: Cofisem - Last Update: 09 May 2019
Key Executives
Chief Executive Officer Emmanuel Petiot
Administrative & Finance Director Julien Coste
VP, Communication Coralie Martin
Investor Relations Coralie Martin
Director Research & Development Georges Gaudriault
Human Resources Director Johane Rinaldi
Source: Cofisem - Last Update: 09 May 2019
Key figures
Millenium 2018 2017 2016 2015 2014
Net sales 39 745 262 209 131
Consumed purchases -9
Payroll 4,737 4,021 3,377 3,230 2,970
Operating profit -10,467 -7,317 -7,692 -7,965 -7,060
Income tax -2,014 1,788 1,115 1,633 1,374
Net income -8,747 -5,163 -6,279 -6,356 -6,458
Fiscal year end 12.18 12.17 12.16 12.15 12.14
Length of fiscal year (month) 12 12 12 12 12
Currency & Unit EUR - thousands EUR - thousands EUR - thousands EUR - thousands EUR - thousands
Account Standards
Source: Cofisem - Last Update: 09 May 2019
Shareholder information
Free float 83.25 %
Truffle Capital 8.87 %
TVM Capital GmbH 7.40 %
Managers and Directors 0.35 %
Founders 0.13 %
Source: Cofisem - Last Update: 08 May 2019

Address

Deinove

Cap Sigma, ZAC Euromédecine II 1682 Rue de la Valsière
FR-34790 Grabels
France
Source: Cofisem - Last Update: 09 May 2019

Contact

Coralie Martin
Phone number: +33 (0)4 48 19 01 60
Source: Cofisem - Last Update: 09 May 2019